Linifanib (ABT 869) is an oral tyrosine kinase inhibitor with antineoplasic activity. As a dual inhibitor, Linifanib, is being tested on several different cancers. Form: Beige Solid Melting Point: 180-183C (dec.) Solubility: DMSO, Methanol
Molecular Weight:
375.4
Form:
Beige Solid
CAS Number:
[796967-16-3]
* VAT and and shipping costs not included. Errors and price changes excepted